Home » Ozempic’s ‘father’ scientists had been awarded the Princess of Asturias Medal

Ozempic’s ‘father’ scientists had been awarded the Princess of Asturias Medal

by admin
Ozempic’s ‘father’ scientists had been awarded the Princess of Asturias Medal

World leaders within the area of endocrinology, Daniel Drucker, Jeffrey Friedman, Joel Habener, Jens Juul Holst and Svetlana Mojsov gained the Princess of Asturias prize for Scientific and Technical Research 2024, for the event of the energetic part of semaglutide, identified commercially as Ozempic. and Wegovy, used to deal with kind 2 diabetes and weight problems.

His analysis has established the endocrine bases of diabetes and weight problems, and has allowed the event of latest efficient medicine to fight each ailments, and to cut back associated pathologies, equivalent to coronary heart illness.

Holst, a researcher on the University of Copenhagen and one of many main specialists within the area of diabetes, discovered that insulin ranges improve and sugar ranges lower in sufferers present process bowel surgical procedure and linked these adjustments to a number of hormones, equivalent to glucagon, produced within the physique. pancreas.

At the identical time, the docs Habener and Drucker, on the one hand, and the biochemist Mojsov, on the opposite, discovered within the USA new varieties of intestinal hormones associated to weight management, GLP-1 and GLP-2, which have labored on a scientific foundation. growth of latest weight problems medicine.

On the opposite hand, Friedman, an knowledgeable in molecular genetics and a researcher at Rockefeller University in New York, focuses his work on the mechanisms that management physique weight and the way the hormone leptin helps to cut back it by lowering meals consumption and growing power expenditure.
The drawback with Ozempic

Semaglutide has the power to imitate a hormone known as ‘glucagon-like peptide 1’ (GLP1), which controls the areas that management urge for food and meals, main individuals who eat to shed pounds, since they really feel happy rapidly.

See also  22 years since the Bojayá massacre

It was developed and launched in 2017 by the Danish pharmaceutical firm Novo Nordisk, however on the finish of 2022 it turned well-known for its means to suppress urge for food, which is why celebrities and ‘influencers’ from all around the world began recommending it. weight reduction, inflicting a worldwide scarcity of the drug and a subsequent ban in some European international locations for sufferers with a medical prescription.

The drug has additionally been investigated a number of occasions for inflicting well being issues or unintended effects, together with alopecia, suicidal ideas, cravings and abdomen issues. Via RT

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy